CEO and CFO Adam Desmond Resigns Amidst Financial Uncertainty; Krystal Eckhart Appointed Interim
summarizeSummary
Selectis Health's CEO and CFO, Adam Desmond, has resigned, receiving a $40,000 severance, with Krystal Eckhart appointed as interim replacement, amidst ongoing financial challenges and a recently failed acquisition bid.
check_boxKey Events
-
CEO and CFO Resignation
Adam Desmond resigned from all positions, including CEO, CFO, and Board member, effective May 14, 2026.
-
Interim Leadership Appointed
Krystal Eckhart, a current Vice President of Revenue Management, was appointed Interim CEO and CFO effective May 15, 2026.
-
Severance Agreement
Desmond received a $40,000 severance payment as part of a separation agreement.
-
Context of Instability
This leadership change follows the recent termination of a tender offer and prior disclosures of going concern doubts and material weaknesses in internal controls.
auto_awesomeAnalysis
The departure of CEO and CFO Adam Desmond, following the termination of a tender offer and the company's disclosure of going concern doubts and material weaknesses, signals significant leadership instability. The appointment of an internal Vice President as interim CEO and CFO suggests a transitional period during a critical time for the micro-cap company.
At the time of this filing, GBCS was trading at $3.55 on OTC in the Real Estate & Construction sector, with a market capitalization of approximately $10.9M. The 52-week trading range was $0.41 to $6.25. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.